CSL Limited (ASX:CSL) Stock Outlook on 2 December 2025: Share Price Slump, Seqirus Spin-Off, New Vaccine Plant and a A$750m Buyback
Updated: 2 December 2025 CSL Limited’s share price has spent most of 2025 in the sin bin, but behind the drawdown sits a mix of solid earnings growth, a radical restructuring, a forthcoming spin‑off of its vaccines arm and fresh news today about a major new vaccine plant and an active on‑market buyback. Together, these developments are reshaping the investment story for one of the ASX’s most important healthcare names. Where the CSL share price stands today At around midday on 2 December 2025, CSL shares were trading near A$182–183, with one widely used data source showing a last price